Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids

Carsten Holzmann,Wolfgang Kuepker,Birgit Rommel,Burkhard Helmke,Joern Bullerdiek
DOI: https://doi.org/10.21873/invivo.11739
In Vivo
Abstract:Our insights into the molecular pathogenesis of uterine smooth muscle tumors have improved significantly. Accordingly, in the present review, we advocate a more refined risk assessment for patients considering surgical removal of fibroids or hysterectomy, respectively, requiring morcellation. For this procedure, the risk estimates given for the iatrogenic spread of a previously unexpected malignancy considerably vary among different studies. Nearly all previous studies conducted retrospectively refer to the risk of a patient having an unexpected malignancy at the time of surgery. We feel that, more appropriately, risk should refer to the number of tumors because, as a rule, every single nodule arises independently and, thus, carries an independent risk of being malignant or not. Furthermore, whether so-called parasitic fibroids carry an underestimated risk of stepwise malignant transformation is discussed.
What problem does this paper attempt to address?